Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marek Ancukiewicz

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2010
Exploratory analysis of early toxicity of sunitinib in advanced hepatocellular carcinoma patients: kinetics and potential biomarker valueAndrew X Zhu, Dan G Duda, Marek Ancukiewicz, et al.
Cancer Medicine|June 1, 2017
Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decadeJoanne W Jang, Michael R Drumm, Jason A Efstathiou, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2009
Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or olderDavid T Miyamoto, Harvey J Mamon, David P Ryan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2013
Potential of 18F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancerNoah C Choi, Tristen T Chun, Andrzej Niemierko, et al.
International Journal of Radiation Oncology, Biology, Physics|March 23, 2012
Dose--volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancerRonald C Chen, Harvey J Mamon, Marek Ancukiewicz, et al.
The Journal of Clinical Endocrinology and Metabolism|November 22, 2007
Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomasJoshua H Petit, Beverly M K Biller, Torunn I Yock, et al.
Plos One|February 21, 2012
Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948)Chandrajit P Raut, Yves Boucher, Dan G Duda, et al.
Journal of Neuro-Oncology|September 24, 2013
Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based studyAyal A Aizer, Marek Ancukiewicz, Paul L Nguyen, et al.
Cancer Research|December 1, 2011
Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusionA Gregory Sorensen, Kyrre E Emblem, Pavlina Polaskova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implicationsAlphonse G Taghian, Rita Abi-Raad, Sherif I Assaad, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2010
Exploratory analysis of early toxicity of sunitinib in advanced hepatocellular carcinoma patients: kinetics and potential biomarker valueAndrew X Zhu, Dan G Duda, Marek Ancukiewicz, et al.
Cancer Medicine|June 1, 2017
Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decadeJoanne W Jang, Michael R Drumm, Jason A Efstathiou, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2009
Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or olderDavid T Miyamoto, Harvey J Mamon, David P Ryan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2013
Potential of 18F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancerNoah C Choi, Tristen T Chun, Andrzej Niemierko, et al.
International Journal of Radiation Oncology, Biology, Physics|March 23, 2012
Dose--volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancerRonald C Chen, Harvey J Mamon, Marek Ancukiewicz, et al.
The Journal of Clinical Endocrinology and Metabolism|November 22, 2007
Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomasJoshua H Petit, Beverly M K Biller, Torunn I Yock, et al.
Plos One|February 21, 2012
Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948)Chandrajit P Raut, Yves Boucher, Dan G Duda, et al.
Journal of Neuro-Oncology|September 24, 2013
Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based studyAyal A Aizer, Marek Ancukiewicz, Paul L Nguyen, et al.
Cancer Research|December 1, 2011
Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusionA Gregory Sorensen, Kyrre E Emblem, Pavlina Polaskova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implicationsAlphonse G Taghian, Rita Abi-Raad, Sherif I Assaad, et al.
Pageof 9